Cargando…
Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases
Introduction: The clinical and therapeutic management of mixed cryoglobulinemia (MC) remains a subject of controversy. In addition, most studies have not recorded the long-term follow-up and the outcome of these cases. Material and Methods: We enrolled 246 patients affected by MC who were consecutiv...
Autores principales: | Mazzaro, Cesare, Dal Maso, Luigino, Mauro, Endri, Gattei, Valter, Ghersetti, Michela, Bulian, Pietro, Moratelli, Giulia, Grassi, Gabriele, Zorat, Francesca, Pozzato, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023473/ https://www.ncbi.nlm.nih.gov/pubmed/29751499 http://dx.doi.org/10.3390/diseases6020035 |
Ejemplares similares
-
Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC)
por: Mazzaro, Cesare, et al.
Publicado: (2021) -
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2021) -
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
por: Quartuccio, Luca, et al.
Publicado: (2022) -
Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy
por: Mazzaro, Cesare, et al.
Publicado: (2022) -
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
por: Quartuccio, Luca, et al.
Publicado: (2022)